Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy

• Główni autorzy: Nadezda Gracheva (Autor), Cristina Müller (Autor), Zeynep Talip (Autor), Stephan Heinitz (Autor), Ulli Köster (Autor), Jan Rijn Zeevaart (Autor), Alexander Vögele (Autor), Roger Schibli (Autor), Nicholas P. van der Meulen (Autor)
• Format: Książka
• Wydane: SpringerOpen, 2019-07-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Background 161Tb is an interesting radionuclide for cancer treatment, showing similar decay characteristics and chemical behavior to clinically-employed 177Lu. The therapeutic effect of 161Tb, however, may be enhanced due to the co-emission of a larger number of conversion and Auger electro...